SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032950
Filing Date
2022-11-18
Accepted
2022-11-18 17:00:49
Documents
71
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1595255
2 ex31-1.htm EX-31.1 19661
3 ex31-2.htm EX-31.2 19856
4 ex32-1.htm EX-32.1 6785
5 ex32-2.htm EX-32.2 7130
  Complete submission text file 0001493152-22-032950.txt   8052721

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20220930.xsd EX-101.SCH 60234
7 XBRL CALCULATION FILE otlc-20220930_cal.xml EX-101.CAL 51158
8 XBRL DEFINITION FILE otlc-20220930_def.xml EX-101.DEF 322849
9 XBRL LABEL FILE otlc-20220930_lab.xml EX-101.LAB 472017
10 XBRL PRESENTATION FILE otlc-20220930_pre.xml EX-101.PRE 408574
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1339066
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 221402634
SIC: 2834 Pharmaceutical Preparations